Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2017  |  Volume : 30  |  Issue : 3  |  Page : 727-733

The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders

1 Department of Pediatrics, Faculty of Medicine, Menoufia University, Menoufia, Egypt
2 Department of Medical Biochemistry, Faculty of Medicine, Menoufia University, Menoufia, Egypt
3 Department of Pediatrics, Quesna Central Hospital, Menoufia, Egypt

Correspondence Address:
Mahmoud S Abou El-Khair
Department of Pediatrics, Quesna Central Hospital, Menoufia, 32631
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1110-2098.218255

Rights and Permissions

Objective The aim of this study was to assess the plasma zinc (Zn)/serum copper (Cu) ratio as a biomarker in children with autism spectrum. Background Autism is a complex, behaviorally defined neurodevelopmental disorder characterized by significant impairments in social interaction, verbal and nonverbal communication, and restrictive, repetitive, and stereotypic patterns of behavior. The possible etiologies that precipitate autism symptoms remain controversial in many cases, but both genetic and environmental factors have been implicated. Children with autism spectrum disorder (ASD) appear to be at risk for Zn deficiency, Cu toxicity, and often have low Zn/Cu ratio. Patients and methods The present study was designed to be of a case–control type. It enrolled 40 children. Twenty patients with autism diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text revision and the Childhood Autism Rating Scales were included. The control group enrolled 20 apparently healthy children, matched to the patients' age and sex. All of them were subjected to biochemical analysis for assessment of plasma Zn level and serum Cu, followed by calculation of plasma Zn/serum Cu ratio. Results Plasma Zn was decreased in patients than in controls. Serum Cu was higher in patients than in controls. Lower Zn/Cu ratio was observed in cases in comparison with controls. intelligence quotient was lower in patients than in controls. There was a correlation between age and Zn/Cu ratio, but there was no correlation between Zn/Cu ratio and BMI. There was a negative correlation between Childhood Autism Rating Scales and Zn/Cu ratio. Zn/Cu correlated negatively with some selected symptom severity in autistic children and Zn/Cu ratio. According to receiver operating characteristic curve, the optimal cutoff value of serum levels of Zn/Cu was projected to be 0.81, with a sensitivity of 85% and a specificity of 85%, and the area under the curve was 0.93. Conclusion Our results suggested an association between blood levels of Zn and Cu with ASD among our patients, and the Zn/Cu ratio could be considered a biomarker of ASD.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded108    
    Comments [Add]    

Recommend this journal